Taking Vitamins but Still Deficient? Your Genes May Be Blocking Absorption.

MTHFR is the enzyme that converts folate and B12 into their active, methylated forms. Methylfolate and methylcobalamin are not optional upgrades. They are the forms your brain, mitochondria, and immune system actually recognize and use. This enzyme is so critical that it sits at the center of the methylation cycle, the biochemical process that runs DNA repair, neurotransmitter production, and detoxification.

The C677T variant, carried by roughly 40 percent of people with European ancestry, reduces MTHFR enzyme efficiency by 40 to 70 percent. That means your cells are converting folate and B12 into usable forms at a fraction of the rate they should be. You can eat a perfect diet rich in leafy greens and take standard folic acid supplements, but your cells may be functionally folate and B12 deficient because the conversion step is broken.

This shows up as persistent fatigue, brain fog, difficulty concentrating, mood instability, and slow healing. Your methylation cycle powers everything from neurotransmitter synthesis to immune function. When it’s sluggish, every system downstream suffers. You feel it as a low hum of dysfunction that bloodwork misses entirely.

Your cells don’t use vitamin D directly. They use a receptor protein called VDR that sits on the cell surface and nucleus. This receptor grabs circulating vitamin D and transports it into the cell, where it activates dozens of genes involved in immune function, bone health, mitochondrial performance, and mood regulation. If your VDR receptor is inefficient, vitamin D cannot enter your cells efficiently, no matter how high your serum levels climb.

VDR variants are extremely common, affecting roughly 30 to 50 percent of the population depending on the specific polymorphism (BsmI, FokI, TaqI). Even a single VDR variant can reduce cellular vitamin D uptake by 30 to 50 percent. People with FokI variants often need 1.7 times more vitamin D to achieve the same cellular effect as people without the variant. You can take 5,000 IU daily and still have a serum level of 50 ng/mL, which looks fine on paper, but your cells are only accessing a fraction of it.

You experience this as persistent fatigue, muscle weakness, bone pain, mood instability, and recurrent infections. Vitamin D deficiency at the cellular level doesn’t show up as low serum vitamin D. It shows up as symptoms that seem disconnected from vitamin D until you understand the VDR story.

Your body has two sources of vitamin A. Preformed retinol comes from animal foods like liver, eggs, and fish. Beta-carotene, a plant-based precursor, comes from carrots, sweet potatoes, kale, and other orange and green vegetables. To use plant-based beta-carotene, your body needs the BCMO1 enzyme to convert it into retinol. This conversion happens primarily in the small intestine and liver. If your BCMO1 enzyme is inefficient, plant-based vitamin A sources become nearly useless.

The R267S and A379V variants in BCMO1 are carried by roughly 45 percent of the population. People with BCMO1 variants can convert beta-carotene to retinol at less than half the rate of people without variants. Some studies show conversion rates drop by 70 to 80 percent. You can eat unlimited carrots and still be vitamin A deficient because the conversion step is too slow to matter.

Vitamin A deficiency shows up as poor night vision, dry skin, recurrent infections, and slow wound healing. Your vision may deteriorate in low light even though you’re eating plenty of beta-carotene-rich foods. Your skin may stay dry and sensitive no matter how much moisturizer you use. Your immune system may be chronically sluggish. These symptoms often get attributed to other causes because the BCMO1 story is rarely considered.

Vitamin D doesn’t float freely in your bloodstream. It’s bound to a transport protein called GC, the vitamin D binding protein. This protein carries vitamin D from your skin and liver throughout your body and delivers it to tissues. But here’s the critical detail: only the unbound, free vitamin D can enter cells and do its job. The rest stays locked in transport. Different GC haplotypes have different binding affinities. Some haplotypes bind vitamin D tightly, leaving less free vitamin D available to tissues. Others bind it loosely, releasing more into circulation.

GC variants are extremely common. Roughly 30 to 50 percent of the population carries a less favorable haplotype (1s, 1f, or 2) that reduces free vitamin D availability. Your serum vitamin D level can be optimal, but if your GC variant binds vitamin D too tightly, your tissues are still vitamin D deficient. This is why some people feel dramatically better when they increase vitamin D supplementation, while others see no change despite high serum levels. The GC genotype determines how much of what you’re taking actually reaches your cells.

You experience GC-driven vitamin D deficiency as bone pain, muscle weakness, immune dysfunction, and sluggish mood. The symptoms are identical to traditional vitamin D deficiency, but the solution is different. You may need higher doses, or you may need to optimize cofactors like magnesium and K2 that enhance the vitamin D that does manage to reach your tissues.

Vitamin C is essential for collagen synthesis, immune function, and antioxidant defense. But like vitamin D, your cells can’t use vitamin C unless it gets transported across the cell membrane. That job belongs to SLC23A1 and SLC23A2, sodium-dependent vitamin C transporters. Without these transporters, vitamin C stays outside your cells, circulates through your bloodstream, and gets excreted in urine. You can consume massive amounts of vitamin C and still be functionally deficient at the cellular level.

Variants in SLC23A1 are carried by roughly 20 to 30 percent of the population. People with SLC23A1 variants have significantly reduced intracellular vitamin C transport, requiring up to 2 to 3 times more dietary vitamin C to achieve adequate cellular levels. Your serum vitamin C may look acceptable on a blood test, but your cells are not receiving enough. This creates a peculiar situation where standard supplementation fails consistently.

You experience SLC23A1-driven vitamin C deficiency as slow wound healing, easy bruising, weak connective tissue, recurrent infections, and poor skin integrity. Your collagen production slows because the vitamin C that builds collagen can’t reach the cells that need it. You get sick more often despite eating citrus and taking supplements. Your skin doesn’t heal well from minor injuries. These symptoms feel like they should respond to more vitamin C, but without fixing the transport step, they don’t.

Your gut bacteria produce B vitamins, particularly B12, B7, and folate. This is a major source of B vitamins for most people. But your bacteria can only produce these vitamins if your gut environment allows it. The FUT2 gene controls whether you secrete certain sugars into your gut lumen. These sugars feed specific bacteria that produce B vitamins. If your FUT2 gene carries a loss-of-function variant, you don’t secrete these sugars, your B-vitamin-producing bacteria starve, and your gut B vitamin production drops dramatically.

The FUT2 nonsecretor variant is carried by roughly 40 percent of the population. People with FUT2 nonsecretor variants have significantly lower gut production of B vitamins and altered bacterial communities that are less efficient at nutrient absorption. They also have reduced absorption of other nutrients like calcium, iron, and zinc. The effect compounds. Your gut is not only making fewer B vitamins, it’s also absorbing fewer of the B vitamins you consume.

You experience FUT2 deficiency as B12 and folate deficiency despite supplementation, chronic fatigue, poor energy, brain fog, and sometimes neurological symptoms like tingling or numbness. Your gut health may seem fine, but the bacterial community is not producing the nutrient cofactors your body needs. Standard supplementation may help slightly, but the real solution involves supporting the bacteria that produce these vitamins or supplementing them directly in high doses.